Neuronetics prices $18M public offering of 8M shares at $2.25/share

Neuronetics, Inc.

Gross proceeds ~$18M from 8M shares (plus underwriter option 1.2M shares exercised).
Net proceeds expected ~$16.4M (or ~$18.9M including option).
Canaccord Genuity LLC sole bookrunner; offering closes Feb 10, 2025.
Proceeds to be used for general corporate purposes including sales, R&D, and acquisitions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.